IL123424A - Transformed derivatives of the N-heterocyclic H12-divenzo [[1,3] d, g] dioxoxin, their preparation and pharmaceutical preparations containing - Google Patents

Transformed derivatives of the N-heterocyclic H12-divenzo [[1,3] d, g] dioxoxin, their preparation and pharmaceutical preparations containing

Info

Publication number: IL123424A
Authority: IL; Israel
Prior art keywords: hydrogen; compound according; halogen; compound; formula
Prior art date: 1995-09-19

Application number

IL12342496A

Other languages

English (en)

Hebrew (he)

Other versions

IL123424A0 (en

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-19

Filing date

1996-09-12

Publication date

2002-02-10

1996-09-12 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1998-09-24 Publication of IL123424A0 publication Critical patent/IL123424A0/xx

2002-02-10 Publication of IL123424A publication Critical patent/IL123424A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

IL12342496A 1995-09-19 1996-09-12 Transformed derivatives of the N-heterocyclic H12-divenzo [[1,3] d, g] dioxoxin, their preparation and pharmaceutical preparations containing IL123424A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK104195		1995-09-19
DK104095		1995-09-19
PCT/DK1996/000382 WO1997011071A1 (en)	1995-09-19	1996-09-12	Novel heterocyclic compounds

Publications (2)

Publication Number	Publication Date
IL123424A0 IL123424A0 (en)	1998-09-24
IL123424A true IL123424A (en)	2002-02-10

Family

ID=26065121

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12342496A IL123424A (en)	1995-09-19	1996-09-12	Transformed derivatives of the N-heterocyclic H12-divenzo [[1,3] d, g] dioxoxin, their preparation and pharmaceutical preparations containing

Country Status (22)

Country	Link
US (6)	US5753678A (es)
EP (1)	EP0851865B1 (es)
JP (1)	JP3499569B2 (es)
KR (1)	KR100437561B1 (es)
CN (1)	CN1090629C (es)
AR (1)	AR004513A1 (es)
AT (1)	ATE220674T1 (es)
AU (1)	AU700784B2 (es)
BR (1)	BR9610524A (es)
CA (1)	CA2231835A1 (es)
CZ (1)	CZ70998A3 (es)
DE (1)	DE69622415T2 (es)
ES (1)	ES2179206T3 (es)
HU (1)	HUP9900079A3 (es)
IL (1)	IL123424A (es)
MX (1)	MX9802126A (es)
NO (1)	NO981216L (es)
PL (1)	PL186708B1 (es)
PT (1)	PT851865E (es)
RU (1)	RU2178790C2 (es)
TW (1)	TW406078B (es)
WO (1)	WO1997011071A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5952352A (en) *	1995-04-07	1999-09-14	Novo Nordisk A/S	Heterocyclic compounds
DK0934312T3 (da) *	1996-10-04	2003-07-21	Novo Nordisk As	1,4-disubstituerede piperaziner
US6040318A (en) *	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
TW200400816A (en)	2002-06-26	2004-01-16	Lilly Co Eli	Tricyclic steroid hormone nuclear receptor modulators
US7723349B2 (en)	2003-04-24	2010-05-25	Incyte Corporation	Aza spiro alkane derivatives as inhibitors of metalloproteases
WO2007143600A2 (en) *	2006-06-05	2007-12-13	Incyte Corporation	Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU174126B (hu) *	1977-08-02	1979-11-28	Egyt Gyogyszervegyeszeti Gyar	Sposob poluchenija novykh proizvodnykh dibenzo-kvadratnaja skobka-d,g-kvadratnaja skobka zakryta-kvadratnaja skobka-1,3,6-kvadratnaja skobka zakryta-dioksazocina
HU195491B (en) *	1985-12-20	1988-05-30	Egyt Gyogyszervegyeszeti Gyar	Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
HU201318B (en) *	1987-12-31	1990-10-28	Egyt Gyogyszervegyeszeti Gyar	Process for producing dioxazoline derivatives and pharmaceutical compositions comprising same
CN1074926A (zh) *	1992-01-29	1993-08-04	大连石油化工公司有机合成厂	混合原油破乳剂的制备方法

1996
- 1996-09-12 WO PCT/DK1996/000382 patent/WO1997011071A1/en not_active Application Discontinuation
- 1996-09-12 AU AU69234/96A patent/AU700784B2/en not_active Ceased
- 1996-09-12 KR KR10-1998-0702036A patent/KR100437561B1/ko not_active IP Right Cessation
- 1996-09-12 AT AT96930027T patent/ATE220674T1/de not_active IP Right Cessation
- 1996-09-12 BR BR9610524A patent/BR9610524A/pt not_active IP Right Cessation
- 1996-09-12 EP EP96930027A patent/EP0851865B1/en not_active Expired - Lifetime
- 1996-09-12 RU RU98107807/04A patent/RU2178790C2/ru not_active IP Right Cessation
- 1996-09-12 HU HU9900079A patent/HUP9900079A3/hu unknown
- 1996-09-12 JP JP51232897A patent/JP3499569B2/ja not_active Expired - Fee Related
- 1996-09-12 CA CA002231835A patent/CA2231835A1/en not_active Abandoned
- 1996-09-12 DE DE69622415T patent/DE69622415T2/de not_active Expired - Fee Related
- 1996-09-12 PT PT96930027T patent/PT851865E/pt unknown
- 1996-09-12 PL PL96325637A patent/PL186708B1/pl not_active IP Right Cessation
- 1996-09-12 IL IL12342496A patent/IL123424A/en not_active IP Right Cessation
- 1996-09-12 CZ CZ98709A patent/CZ70998A3/cs unknown
- 1996-09-12 MX MX9802126A patent/MX9802126A/es not_active IP Right Cessation
- 1996-09-12 CN CN96197078A patent/CN1090629C/zh not_active Expired - Fee Related
- 1996-09-12 ES ES96930027T patent/ES2179206T3/es not_active Expired - Lifetime
- 1996-09-18 US US08/715,665 patent/US5753678A/en not_active Expired - Fee Related
- 1996-09-18 AR ARP960104401A patent/AR004513A1/es unknown
- 1996-09-30 TW TW085111986A patent/TW406078B/zh not_active IP Right Cessation
1997
- 1997-09-04 US US08/922,977 patent/US5972925A/en not_active Expired - Fee Related
- 1997-10-24 US US08/957,163 patent/US5912262A/en not_active Expired - Fee Related
- 1997-10-24 US US08/957,172 patent/US5917047A/en not_active Expired - Fee Related
1998
- 1998-03-18 NO NO981216A patent/NO981216L/no not_active Application Discontinuation
- 1998-05-15 US US09/079,599 patent/US6017915A/en not_active Expired - Fee Related
- 1998-05-15 US US09/079,935 patent/US5916901A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PL325637A1 (en)	1998-08-03
CN1090629C (zh)	2002-09-11
HUP9900079A3 (en)	2000-02-28
PL186708B1 (pl)	2004-02-27
DE69622415T2 (de)	2003-03-06
TW406078B (en)	2000-09-21
US6017915A (en)	2000-01-25
NO981216D0 (no)	1998-03-18
BR9610524A (pt)	1999-07-06
DE69622415D1 (de)	2002-08-22
US5916901A (en)	1999-06-29
AU700784B2 (en)	1999-01-14
ES2179206T3 (es)	2003-01-16
AU6923496A (en)	1997-04-09
US5912262A (en)	1999-06-15
NO981216L (no)	1998-03-18
IL123424A0 (en)	1998-09-24
CN1196729A (zh)	1998-10-21
EP0851865A1 (en)	1998-07-08
MX9802126A (es)	1998-05-31
WO1997011071A1 (en)	1997-03-27
KR19990063593A (ko)	1999-07-26
ATE220674T1 (de)	2002-08-15
CZ70998A3 (cs)	1998-08-12
JP3499569B2 (ja)	2004-02-23
RU2178790C2 (ru)	2002-01-27
PT851865E (pt)	2002-11-29
US5917047A (en)	1999-06-29
AR004513A1 (es)	1998-12-16
US5972925A (en)	1999-10-26
EP0851865B1 (en)	2002-07-17
CA2231835A1 (en)	1997-03-27
HUP9900079A2 (hu)	1999-10-28
KR100437561B1 (ko)	2004-07-16
JPH11506470A (ja)	1999-06-08
US5753678A (en)	1998-05-19

Legal Events

Date	Code	Title
2002-06-30	FF	Patent granted
2002-08-14	KB	Patent renewed
2002-11-10	KB	Patent renewed
2007-07-24	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
EP0820451B1 (en)	2003-01-15	Novel heterocyclic compounds
US20020151539A1 (en)	2002-10-17	Novel heterocyclic compounds
US5780486A (en)	1998-07-14	Heterocyclic compounds
AU700784B2 (en)	1999-01-14	Novel heterocyclic compounds
US6110913A (en)	2000-08-29	N-substituted azaheterocyclic carboxylic acids and esters thereof
US6071901A (en)	2000-06-06	Substituted dibenz[b,f]azepines and uses thereof
EP0869954B1 (en)	2001-09-19	Heterocyclic compounds for use in the treatment of neurogenic inflammation
US6214816B1 (en)	2001-04-10	Heterocyclic compounds
US6613791B1 (en)	2003-09-02	N-substituted azaheterocyclic carboxylic acids and their use
US5827856A (en)	1998-10-27	Method of treating insulin resistance
WO1998015550A1 (en)	1998-04-16	N-substituted azaheterocyclic compounds
US5952352A (en)	1999-09-14	Heterocyclic compounds
US6187770B1 (en)	2001-02-13	N-substituted azaheterocyclic compounds
WO1996031474A1 (en)	1996-10-10	Novel heterocyclic compounds
EP1071679A1 (en)	2001-01-31	Novel heterocyclic compounds
WO1996031503A1 (en)	1996-10-10	Novel heterocyclic compounds
EP1071686A1 (en)	2001-01-31	Novel heterocyclic compounds